Search the Newsreel

H.C. Wainwright Maintains Minerva Neurosciences(NERV.US) With Hold Rating, Maintains Target Price $7

H.C. Wainwright has reiterated its Hold rating for Minerva Neurosciences (NERV.US) and maintained a target price of $7. This indicates the firm's continued neutral outlook on the company's stock performance.

Euronet Worldwide Inc E2EF34 Titulares - Distribuição de Posse de Ações

Energy drinks give Keurig Dr Pepper a boost

Keurig Dr Pepper experienced mixed results in Q2, with energy drinks boosting market share to over 9% and driving net sales up by 76%. However, US Coffee volumes declined, impacting overall earnings despite a 7.3% rise in net sales excluding the JDE Peet’s acquisition. …

Neuronetics outlines 2026 revenue of $160M-$164M while shifting NeuroStar to broader ownership models

Earnings Call Insights: Neuronetics (STIM) Q2 2026 MANAGEMENT VIEW * "I'm pleased to report the second quarter began to reflect our steady execution against the goals I cited last quarter. Total revenue was $41.6 million, up approximately 9% versus the second quarter of last …

LVMH: Share transactions disclosure

LVMH Paris, August 11th, 2026 The disclosure of share transactions carried out from August 3rd to August 7th, 2026, was sent to the AMF on August 11th 2026. As required by current law, this document is publically available and can be consulted on the …

If You Invested $1,000 in WaveDancer, Inc. (WAVD)

This article analyzes the historical performance of a $1,000 investment in WaveDancer, Inc. (WAVD) over different periods, providing details on its annual returns and cumulative growth. It also explains WaveDancer's significant transformation from an IT services company to a medical technology and AI company …

Neurogene Q2 Results: EPS widens to $(1.53), misses estimates

Neurogene (NASDAQ:NGNE) Stock Price Down 7.8% on Disappointing Earnings

Neurogene (NASDAQ:NGNE) Posts Earnings Results, Misses Expectations By $0.11 EPS

Neuronetics (NASDAQ:STIM) Announces Earnings Results

Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23%

Neuronetics, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Operational Discipline Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Neuronetics publishes investor presentation on NeuroStar TMS, Greenbrook clinic network strategy

Neuronetics has released an investor presentation detailing its NeuroStar TMS and Greenbrook clinic network strategy. The company provided FY 2026 revenue guidance of $160 million to $164 million, projecting 7% to 10% year-on-year growth, alongside a gross margin outlook of 48% to 50%. It …

Neuronetics STIM Draws Buy Rating As Vertical Psychiatry Platform Scales Up

Neuronetics (STIM) has received a "Buy" rating and a $5 target price from BTIG, signaling bullish sentiment due to its expanding depression-treatment technology adoption and vertically integrated psychiatry platform. The company's acquisition of 93 Greenbrook-operated treatment centers and the establishment of a National Center …

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification

NeuroOne Medical Technologies Corporation has announced it received ISO 13485-2016 certification, an international standard for Quality Management Systems in the Medical Device Industry. This certification allows NeuroOne to pursue international marketing opportunities for its Evo® Cortical and Evo® sEEG Electrodes, and the OneRF® Brain …

Euronet to offer credit issuing platform in Peru

Euronet has partnered with Unibanca, a Peruvian payment services company, to provide its CoreCard credit issuing platform as a software-as-a-service (SaaS) solution in Peru. This collaboration aims to enhance Unibanca's service offerings, enabling them to provide advanced credit solutions like Buy Now Pay Later …

Firefly Neuroscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Why Euro Sun Mining Inc stock surged yesterday

Neuronetics stock soars 15% on second quarter earnings beat

Neuronetics (NASDAQ:STIM) reported strong second-quarter results, surpassing analyst expectations with an adjusted loss per share of -$0.05 and revenue of $41.6 million. The company's stock surged over 15% in pre-market trading, driven by a 9.1% year-over-year revenue increase, primarily from its Greenbrook clinic segment. …

Neuronetics Reports Second Quarter 2026 Results, Highlights Revenue Growth and Improved Adjusted EBITDA

Neuronetics, Inc. reported a 9.1% increase in total revenue to $41.6 million for Q2 2026, driven by a 16.8% rise in Greenbrook healthcare clinic revenue. The company also significantly improved its adjusted EBITDA to $0.3 million and reduced its net loss to $3.4 million. …

What is Noble Financial's Estimate for EuroDry Q3 Earnings?

NEURONETICS ($STIM) Releases Q2 2026 Earnings

Neuronetics: Q2 Earnings Snapshot

Euroseas Ltd. Sets Date for the Release of Second Quarter 2026 Results, Conference Call and Webcast

Euroseas Ltd. has announced that it will release its financial results for the second quarter ended June 30, 2026, on Monday, August 25, 2026. The company will also host a conference call and webcast on the same day to discuss the results. This event …

Neurogene: Q2 Earnings Snapshot

Keurig Dr Pepper's 7Up leads with lime in its first brand refresh in 15 years (KDP:NASDAQ)

Keurig Dr Pepper's 7Up brand is undergoing its first major refresh in over 15 years, aiming to redefine the $5 billion lemon-lime beverage category. The core of this refresh is a lime-led reformulation of the drink.

Keurig Dr Pepper's 7Up leads with lime in its first brand refresh in 15 years

[7UP Delivery Truck in Cleveland, Ohio] RiverNorthPhotography/iStock Unreleased via Getty Images Keurig Dr Pepper's (KDP [https://seekingalpha.com/symbol/KDP]) 7Up brand is going through its first major refresh in more than 15 years as the company looks to redefine the $5B lemon-lime category, with a lime-led reformulation …

Keurig Dr Pepper Inc. (KDP) Stock Forecasts

This article provides a stock forecast for Keurig Dr Pepper Inc. (KDP), highlighting its current price, fair value, and economic moat. It notes that the company was formed in 2018 through a merger and faces execution risks as it works to separate its coffee …

Euronet Worldwide (NASDAQ:EEFT): A Decent Value Stock Worth Researching

Valeura Energy Inc (TSX:VLE): The Turnaround Play That Turned Doubters Into Believers

B&M European Value Retail (LON:BME) Stock Crosses Above 50-Day Moving Average - Here's What Happened

NPCE Q1 2026 Earnings: EPS Beats Consensus, Shares Edge Higher - Earnings Miss Streak

AIFF Q3 1998 Earnings: EPS Plunges to -12.9 vs. 3.366 Estimate, a -483.24% Shock - Quarterly Earnings Report

JUNS Q4 2025 Earnings: Narrower-Than-Expected Loss of $5.025 per Share but No Revenue Weighs on Shares - Earnings Beat Alert

Jupiter Neurosciences (JUNS) Tumbles 11.5% to $4.70 as Key Support Level Comes into Focus - Sentiment Shift

Jupiter Neurosciences Inc (JUNS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Jupiter Neurosciences Inc (JUNS), indicating that no earnings forecast score is currently available, while the industry average is 8.10. Based on one analyst, the stock has a "Buy" rating with a target price of 25.000, representing 0.00% …